Maintenance of naive and Th1 CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens.

Source:http://linkedlifedata.com/resource/pubmed/id/11707681

J. Acquir. Immune Defic. Syndr. 2001 Dec 1 28 4 401-3

Download in:

View as

General Info

PMID
11707681